Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Matrix metalloproteinase-9 (MMP-9)
100%
NF-B
100%
Tight Junction Barrier
100%
Intestinal Tight Junction
100%
Inflammatory Bowel Disease
36%
Caco-2
36%
Tight Junction
18%
Barrier Function
18%
Myosin Light Chain Kinase
18%
Intestinal Permeability
18%
Matrix Effect
9%
Inflammation
9%
Pathogenic Factors
9%
Small Interfering RNA (siRNA)
9%
Molecular Mechanism
9%
Knockdown
9%
Protein Expression
9%
Necrosis
9%
Apoptosis
9%
Intracellular Signaling
9%
Interleukin-8
9%
Induced Expression
9%
Nuclear Translocation
9%
In Vitro Model System
9%
RB Pathway
9%
Stool
9%
Intestinal Tissue
9%
Tissue Damage
9%
Pathway Activation
9%
Intestinal Inflammation
9%
Caco-2 Cell Monolayer
9%
Intestinal Barrier Function
9%
Kinase Protein
9%
Medicine and Dentistry
Tight Junction
100%
Gelatinase B
100%
Caco-2
45%
Patient with Inflammatory Bowel Disease
18%
Intestinal Permeability
18%
Myosin Light Chain Kinase
18%
Inflammatory Bowel Disease
18%
In Vitro
9%
Genetic Transfection
9%
Protein Expression
9%
Small Interfering RNA
9%
Programmed Cell Death
9%
Necrosis
9%
Tissue Injury
9%
Enteritis
9%
Inflammation
9%
Immunology and Microbiology
Tight Junction
100%
Inflammatory Bowel Disease
50%
Light Chain
25%
Myosin
25%
Phosphotransferase
25%
Kinase
25%
Genetic Transfection
12%
Protein Expression
12%
Enteritis
12%
Interleukin 8
12%
Programmed Cell Death
12%
In Vitro
12%
Inflammation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Gelatinase B
100%
Inflammatory Bowel Disease
36%
Intestinal Permeability
18%
Myosin Light Chain Kinase
18%
Inflammation
9%
Necrosis
9%
Tissue Injury
9%
Small Interfering RNA
9%
Enteritis
9%